Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CPC-211small molecule inhibitor of lactate accumulation: Began ascending dose, Phase II trial in 20 patients. Brain imaging will be carried out pre- and post-dr

Cypros Pharmaceutical Corp. (CYPR),

Read the full 43 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE